SMALLCAPSDAILYNews / Catalysts / OpportunityGet the Daily Brief
Ticker Hub

NUNZ

NUNZIA PHARMACEUTICL CORP

Latest price

——

As of — · Market data by Massive

Market cap

—

Volume

—

Previous close

—

Day range

—

Listed

—

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET
Intraday chart history is not available yet.

Newsroom

Latest NUNZ coverage

Nunzia Pharmaceutical Corporation (OTC:NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, has Signed a Licensing Agreement with Michael Mitsunaga for the Exclusive Patent Rights to his IV BLOOD WARMER
NewsAug 7, 2021

Nunzia Pharmaceutical Corporation (OTC:NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, has Signed a Licensing Agreement with Michael Mitsunaga for the Exclusive Patent Rights to his IV BLOOD WARMER

[ad_1] San Clemente, CA – (NewMediaWire) – August 06, 2021 – Nunzi Pharmaceutical Corporation (OTC:NUNZ) entered into a License Agreement with Michael Mitsunaga as stated in the 8K filing of 08/05/2021. Under the terms of the Agreement, Nunzia has the exclusive license to use the following items of intellectual property: IV BLOOD WARMING SY

NUNZ
Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.